OCC
ORTHOCELL FPO [OCC]
Healthcare · ASX Small Cap
$0.7250 -0.7%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-03-03
Get alerts when OCC triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Sitting near support — this level has held before and could attract buyers again
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Strong cash runway (14 quarters)
- Strong revenue growth (+42%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (3% of range)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +42% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.84%/day)
- Beneish M-Score -2.01 (grey zone -2.22 to -1.78): possible earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-122%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 28% over the past year
Expected next for OCC
Window: 18 Oct to 1 Nov
The last 4 moved OCC +2.4% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Appendix 4G
NONE Corporate Governance Statement
LOW Appendix 4E & Annual Report
LOW Orthocell Canaccord Genuity Conference Live Webcast
LOW Orthocell to Present at Canaccord Growth Conference
Recent ASX Announcements
| 2026-08-31 | Appendix 4G |
| 2026-08-31 | Corporate Governance Statement |
| 2026-08-31 | Appendix 4E & Annual Report PRICE SENSITIVE |
| 2026-08-11 | Orthocell Canaccord Genuity Conference Live Webcast |
| 2026-08-10 | Orthocell to Present at Canaccord Growth Conference |
Key Metrics
$198.8M
Market Cap
195K
Avg Volume
0.7x
Vol Ratio
$0.70 — $1.60
52-Week Range
0.3%
Short Interest
N/A
Cash Runway
-56.8%
ROE
-122.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 84% |
| L | Leader vs Laggard | laggard | RS: -3 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track OCC and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required